Budd-Chiari syndrome: Combination of genetic defects and the use of oral contraceptives leading to hypercoagulability

Journal of Hepatology

Volumn 33, Issue 3, 2000, Pages 509-512

  Minnema, Monique C ^a   Janssen, Harry L A ^b   Niermeijer, Peter ^a   Man, Robert A de ^b  

^a Gooi Noord Hospital   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Budd Chiari Syndrome; Factor V Leiden mutation; Hepatic outflow; Obstruction; Prothrombin gene mutation; Risk factors for thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; DESOGESTREL PLUS ETHINYLESTRADIOL; ORAL CONTRACEPTIVE AGENT;

ABDOMINAL PAIN; ADULT; ARTICLE; ASCITES; BUDD CHIARI SYNDROME; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; GENE MUTATION; GENETIC DISORDER; GENETIC PREDISPOSITION; GENETIC RISK; HUMAN; HUMAN TISSUE; HYPERCOAGULABILITY; LIVER BIOPSY; PRIORITY JOURNAL; RISK FACTOR; THROMBOSIS;

EID: 0033841341     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(00)80290-1     Document Type: Article

References (26)

1. Budd-Chiari syndrome: Etiology, diagnosis and management
2. Primary myeloproliferative disorder and hepatic vein thrombosis: A prospective study of erythroid colony formation in vitro in 20 patients with Budd- Chiari syndrome
3. Hepatic vein thrombosis in paroxysmal nocturnal hemoglobinuria: A spectrum from asymptomatic occlusion of hepatic venules to fatal Budd-Chiari syndrome
4. Risk of hepatic vein thrombosis in relation to recent use of oral contraceptives: A case-control study
5. Case records of the Massachusetts General Hospital, Case 12-1996
6. Antithrombin III deficiency: An etiology of Budd-Chiari syndrome
7. Budd-Chiari syndrome and factor V Leiden mutation
8. Budd-Chiari syndrome and factor V Leiden mutation
9. Acute Budd-Chiari syndrome with fulminant hepatic failure in a pregnant woman with factor V Leiden mutation
10. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
11. Mutation in blood coagulation factor V associated with resistance to activated protein C
12. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study
13. Prevalence of the factor V Leiden mutation in hepatic and portal vein thrombosis
14. Factor V Leiden mutation and Budd-Chiari syndrome
15. Prevalence of the factor V Leiden mutation in portal and hepatic vein thrombosis
16. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation prostagen
17. Oral contraceptives and venous thrombosis: Different sensitivities to activated protein C in women using second- and third-generation oral contraceptives
18. Budd-Chiari syndrome in a patient heterozygous for the G20210A mutation of the prothrombin gene
19. The prothrombin gene 3'-untranslated region is frequently associated with factor V Leiden in thrombophilic patients and shows ethnic-specific variation in allele frequency
20. Co-inheritance of the 20210A allele of the prothrombin gene increases the risk of thrombosis in subjects with familial thrombophilia
21. The prothrombin 20210 A allele is frequently coinherited in young carriers of the factor V Arg 506 to Gln mutation with venous thrombophilia
22. Venous thrombosis: A multicausal disease
23. Acute Budd-Chiari syndrome due to inferior vena cava occlusion following blunt trauma
24. Budd-Chiari syndrome resulting from intrahepatic IVC compression secondary to blunt hepatic trauma
25. Post-traumatic membranous obstruction of the inferior vena cava associated with a hypercoagulable state
26. Factor V Leiden mutation, prothrombin gene mutation and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis